Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association - PubMed (original) (raw)
Review
doi: 10.2337/diacare.27.1.256.
David Bell, Robert O Bonow, Vivian Fonseca, Scott M Grundy, Edward S Horton, Martin Le Winter, Daniel Porte, Clay F Semenkovich, Sidney Smith, Lawrence H Young, Richard Kahn
Affiliations
- PMID: 14693998
- DOI: 10.2337/diacare.27.1.256
Review
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association
Richard W Nesto et al. Diabetes Care. 2004 Jan.
No abstract available
Comment in
- Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: response to Nesto.
Elasy TA, Griffin M. Elasy TA, et al. Diabetes Care. 2004 Aug;27(8):2096; author reply 2096. doi: 10.2337/diacare.27.8.2096. Diabetes Care. 2004. PMID: 15277462 No abstract available.
Similar articles
- Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association. Nesto RW, et al. Circulation. 2003 Dec 9;108(23):2941-8. doi: 10.1161/01.CIR.0000103683.99399.7E. Circulation. 2003. PMID: 14662691 Review. No abstract available. - Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association: response to Nesto.
Elasy TA, Griffin M. Elasy TA, et al. Diabetes Care. 2004 Aug;27(8):2096; author reply 2096. doi: 10.2337/diacare.27.8.2096. Diabetes Care. 2004. PMID: 15277462 No abstract available. - [Heart failure with thiazolidinedione treatment: what do we know today?].
Erdmann E. Erdmann E. Dtsch Med Wochenschr. 2009 Jan;134(4):154-8. doi: 10.1055/s-0028-1123973. Epub 2009 Jan 15. Dtsch Med Wochenschr. 2009. PMID: 19148858 Review. German. - Thiazolidinedione-induced edema in patients with heart failure.
Stroup JS. Stroup JS. Am J Health Syst Pharm. 2007 Dec 1;64(23):2426-30; author reply 2430. doi: 10.2146/ajhp070371. Am J Health Syst Pharm. 2007. PMID: 18029947 No abstract available. - Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
Wang F, Vergara C, Carabino J, Desilets A, Vasquez R. Wang F, et al. Am J Health Syst Pharm. 2004 Aug 1;61(15):1604-8. doi: 10.1093/ajhp/61.15.1604. Am J Health Syst Pharm. 2004. PMID: 15372837 No abstract available.
Cited by
- A Convenient Synthesis of Short α-/β-Mixed Peptides as Potential α-Amylase Inhibitors.
Ahmed N, Razzaq F, Arfan M, Gatasheh MK, Nasir H, Ali JS, Hafeez H. Ahmed N, et al. Molecules. 2024 Aug 26;29(17):4028. doi: 10.3390/molecules29174028. Molecules. 2024. PMID: 39274877 Free PMC article. - Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients.
Fatemi Y, Nikfar M, Oladazimi A, Zheng J, Hoy H, Ali H. Fatemi Y, et al. Healthcare (Basel). 2024 Jun 8;12(12):1165. doi: 10.3390/healthcare12121165. Healthcare (Basel). 2024. PMID: 38921280 Free PMC article. - Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization.
Rohm TV, Castellani Gomes Dos Reis F, Isaac R, Murphy C, Cunha E Rocha K, Bandyopadhyay G, Gao H, Libster AM, Zapata RC, Lee YS, Ying W, Miciano C, Wang A, Olefsky JM. Rohm TV, et al. Nat Metab. 2024 May;6(5):880-898. doi: 10.1038/s42255-024-01023-w. Epub 2024 Apr 11. Nat Metab. 2024. PMID: 38605183 - PPARγ Agonist Rosiglitazone and Antagonist GW9662: Antihypertensive Effects on Chronic Intermittent Hypoxia-Induced Hypertension in Rats.
Zhang N, Wei F, Ning S, Hu J, Shi H, Yao Z, Tang M, Zhang Y, Gong J, Ge J, Cui Z. Zhang N, et al. J Cardiovasc Transl Res. 2024 Aug;17(4):803-815. doi: 10.1007/s12265-024-10499-6. Epub 2024 Feb 27. J Cardiovasc Transl Res. 2024. PMID: 38411834 - Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies.
Genua I, Cusi K. Genua I, et al. Diabetes Spectr. 2024 Winter;37(1):48-58. doi: 10.2337/dsi23-0012. Epub 2024 Feb 15. Diabetes Spectr. 2024. PMID: 38385098 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical